ASYLIA DIAGNOSTICS

asylia-diagnostics-logo

Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated by the standard of care. We then use our data platform and AI-powered technology to transform these highly heterogeneous patient populations into well-defined subgroups that share common molecular and immuno-pathophysiology profiles. By doing t... his, we are able to identify highly specific biomarkers and novel drug targets. We then use discovered endotypes, biomarkers, and drug targets to develop patient stratification, enrichment, and indication expansion strategies, early hits/leads for the therapeutic pipeline, and eventually complex theranostic products together with our biopharma and IVD partners.

#SimilarOrganizations #People #Financial #Website #More

ASYLIA DIAGNOSTICS

Social Links:

Industry:
Artificial Intelligence (AI) Biotechnology Health Care Life Science Precision Medicine

Founded:
2019-08-22

Address:
Delaware City, Delaware, United States

Country:
United States

Website Url:
http://www.asyliadx.com

Total Employee:
1+

Status:
Active

Contact:
+32 492 40 40 24

Email Addresses:
[email protected]

Total Funding:
1.1 M USD

Technology used in webpage:
Euro Google Google Cloud Wix


Similar Organizations

akello-logo

Akello

Open Source Health Data Platform for Enterprise

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

perceiv-ai-logo

Perceiv AI

AI-driven precision medicine, forecasting disease progression

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโ€‘based treatments for cardiovascular disease.

sf17-therapeutics-logo

SF17 Therapeutics

SF17 Therapeutics is a precision medicine analytics platform.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Founder


not_available_image

Andrey Khmelevskiy

not_available_image

Anna Kostikova

Investors List

imec_image

imec

imec investment in Seed Round - Asylia Diagnostics

davidovs-vc_image

Davidovs Venture Collective

Davidovs Venture Collective investment in Seed Round - Asylia Diagnostics

bluehealth-innovation-center_image

BlueHealth Innovation Center

BlueHealth Innovation Center investment in Seed Round - Asylia Diagnostics

Official Site Inspections

http://www.asyliadx.com Semrush global rank: 13.31 M Semrush visits lastest month: 78

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Asylia Diagnostics"

Asylia Diagnostics

Asylia Diagnostics focuses on the field of immunotherapies. We collect molecular, chemical and real-world evidence data. Our data come from patients treated with investigational drugs in clinical trials, from patients treated by the standard of โ€ฆSee details»

HOME | Asylia Diagnostics

Asylia Diagnostics is a precision medicine company focusing on the field of immunotherapies. We collect molecular and real-world evidence data from patients treated with investigational drugs in clinical trials and patients treated โ€ฆSee details»

ABOUT - Asylia Diagnostics

Asylia has set up a multi-disciplinary scientific team uniquely positioned to deliver precision medicine tools thanks to a combination of technical, biological, and laboratory skills acquired โ€ฆSee details»

Asylia Diagnostics - Crunchbase Company Profile

Asylia Diagnostics is a diagnostics technology platform intended to provide safer immunotherapy for cancer patients. We collect molecular and real-world โ€ฆSee details»

Asylia Diagnostics - Overview, News & Similar companies

View Asylia Diagnostics (www.asyliadx.com) location in Belgium , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Asylia Diagnostics - PitchBook

Asylia Diagnostics General Information Description. Developer of molecular diagnostics tests designed to provide safer immunotherapy for cancer patients. The company's approach is โ€ฆSee details»

Asylia Diagnostics BV - Drug pipelines, Patents, Clinical trials

Last update 01 Nov 2024. Asylia Diagnostics BVSee details»

Asylia Diagnostics BV - LinkedIn

Asylia Diagnostics BV | 333 followers on LinkedIn. Diagnostics technology platform intended to provide safer immunotherapy for cancer patients | Asylia, a precision medicine platform, โ€ฆSee details»

Asylia Diagnostics - VentureRadar

"Asylia Diagnostics is a data-driven company specializing in the field of immunotherapies. They leverage a proprietary generative AI platform, AsyliaAIโ„ข, to analyze multi-modal datasets โ€ฆSee details»

Asylia Diagnostics | VentureRadar

Website: https://www.asyliadx.com/ Asylia Diagnostics is a data-driven company specializing in the field of immunotherapies. They leverage a proprietary generative AI ...See details»

Asylia Diagnostic - CMOCRO

Asylia Diagnostics are building a technology platform that will permit a quick and efficient high-resolution profiling of tumor microenvironment, different immune cells and their subtypes, and โ€ฆSee details»

Startup story Asylia Diagnostics - Imec.istart

Oct 21, 2020 Immunotherapy is becoming more and more effective in fighting cancer. Asylia Diagnostics develops tests to make the innovative therapy safer. โ€œBelgium is a frontrunner in โ€ฆSee details»

Asylia Diagnostics BV (Asylia Diagnostics BV) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ โ€ฆ

The recent approval of ICB treatments targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1/PD-L1) by the US Food and Drug Administration has offered โ€ฆSee details»

Asylia Diagnostics - Products, Competitors, Financials, Employees ...

Asyliadx.com. Overview & Products; Financials; People; Founded Year 2016. Stage Seed VC | Alive. Total Raised $250K. Last Raised $190K | 3 yrs ago. About Asylia Diagnostics. Asylia โ€ฆSee details»

OUR APPROACH | Asylia Diagnostics

At the core of our technology is back-translation - a transformative concept that leverages molecular and clinical RWE data and machine learning/AI and allows us to de-risk upfront โ€ฆSee details»

Working at Asylia Diagnostics - Glassdoor

See what employees say it's like to work at Asylia Diagnostics . Salaries, reviews, and more - all posted by employees working at Asylia Diagnostics .See details»

PIPELINE - Asylia Diagnostics

Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational biology, real-world evidence data, and fast โ€ฆSee details»

NEWS - Asylia Diagnostics

Our CEO Andrey Khmelevskiy had an interview with Sofie Van Poucke for Invest in Flanders.They discussed why what we do in Asylia Diagnostics BV is important for clinicians and cancer โ€ฆSee details»

News - Asylia Diagnostics

JLABS @ BE, Janssen Pharmaceutica NV Beerse Site 1, Turnhoutseweg 30, 2340 Beerse, Belgium. [email protected]. ContactSee details»

linkstock.net © 2022. All rights reserved